Providers

Greater Disease Burden in Patients With Skin and Joint Symptoms for Psoriatic Arthritis

July 30, 2020

Article

Patients who have both skin and joint symptoms with psoriatic arthritis have greater disease burden and worse quality of life compared with patients who have joint-only involvement.

The Race to Find a COVID-19 Vaccine

July 28, 2020

Article

The race for a coronavirus disease 2019 (COVID-19) vaccine is one of the most urgent public health challenges, with multiple vaccine candidates entering phase 3 trials and case counts around the world steadily climbing. MJH Life Sciences™ will host a free webinar with the top minds in infectious disease, virology, and vaccinology to discuss the latest trial information on vaccines.

Tocilizumab Caused Serious AEs in a Quarter of Children With Rheumatic Inflammatory Diseases

July 25, 2020

Article

In children with inflammatory rheumatic diseases, tocilizumab can cause serious adverse events (AEs), with children who were younger at disease onset and at time of tocilizumab initiation especially affected.

One in 5 Patients With MS Don't Adhere to Oral DMDs

July 24, 2020

Article

The researchers noted that these results can help inform therapeutic decision making and identify opportunities to address barriers to disease-modifying drug (DMD) adherence, which not only improves clinical outcomes but also reaps benefits when it comes to health care costs.

Transitioning Adolescents With Lupus From Pediatric to Adult Care

July 23, 2020

Article

Transferring from pediatric to adult care can result in difficulties for patients with childhood-onset systemic lupus erythematosus.

Secukinumab Dose Escalation, Retention Rate, and Safety in Real-World Settings

July 23, 2020

Article

In 2 studies of secukinumab use in real-world settings, researchers identified the usefulness of dose escalation in patients with psoriatic arthritis (PsA), as well as the safety, retention rate, and factors associated with drug survival among patients with PsA and ankylosing spondyloarthritis.

Therapy Provides Readily Available Stem Cell Source to Treat Rare Genetic Diseases

July 22, 2020

Article

Umbilical cord blood provides a readily available source of stem cells to provide better access to hematopoietic stem cell transplantation to safely and effectively treat various noncancerous genetic disorders in children.

Experimental Vaccines Show Promise Against COVID-19 in Healthy Subjects

July 21, 2020

Article

Two experimental vaccines, one from AstraZeneca and the other from CanSino Biologics, have shown promising results against coronavirus disease 2019 (COVID-19) in a phase 1/2 trial and a phase 2 trial. Results for both were published in The Lancet.

Identifying Factors of Delayed Diagnosis in Axial Spondyloarthritis

July 16, 2020

Article

Although early diagnosis of axial spondyloarthritis is crucial for patients to receive timely access to care and effective treatment, these patients experience a diagnostic delay of more than 7 years, on average.